(Q40518562)

21 September 2017

title

Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture (English)

1 reference

21 September 2017

1 reference

2

Suresh K Mittal

1 reference

21 September 2017

Dinesh S Bangari

1

1 reference

21 September 2017

publication date

1 October 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

105

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

127-136

1 reference

Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Sequence analysis of porcine adenovirus type 3 E1 region, pIX and pIVa2 genes, and two novel open reading frames

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Replicative adenoviruses for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

A system for the propagation of adenoviral vectors with genetically modified receptor specificities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Replication-defective vector based on a chimpanzee adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

General strategy for broadening adenovirus tropism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

CD46 is a cellular receptor for group B adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Manipulation of adenovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

A new technique for the assay of infectivity of human adenovirus 5 DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Phylogenetic perspectives in innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Development of a bovine adenovirus type 3-based expression vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

A high-efficiency Cre/loxP-based system for construction of adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Development of adenovirus serotype 35 as a gene transfer vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Development of porcine adenovirus-3 as an expression vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Sequence and transcription map analysis of early region-1 of porcine adenovirus type-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Gene therapy progress and prospects: adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Generation of infectious genome of bovine adenovirus type 3 by homologous recombination in bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Development and characterization of bovine x human hybrid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Characterization of bovine adenovirus type 3 E1 proteins and isolation of E1-expressing cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

A recombinant E1-deleted porcine adenovirus-3 as an expression vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

The E1 sequence of bovine adenovirus type 3 and complementation of human adenovirus type 5 E1A function in bovine cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

Combinatorial blockade of calcineurin and CD28 signaling facilitates primary and secondary therapeutic gene transfer by adenovirus vectors in dystrophic (mdx) mouse muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.05.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2004.05.003

1 reference

21 September 2017

1 reference